中国基层医药
中國基層醫藥
중국기층의약
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
2013年
11期
1606-1608
,共3页
黄一统%唐少华%柯晓慧%叶枫%潘晨翔
黃一統%唐少華%柯曉慧%葉楓%潘晨翔
황일통%당소화%가효혜%협풍%반신상
宫颈环形电切术%重组人干扰素α-2b栓%宫颈上皮内瘤样变%人乳头瘤病毒
宮頸環形電切術%重組人榦擾素α-2b栓%宮頸上皮內瘤樣變%人乳頭瘤病毒
궁경배형전절술%중조인간우소α-2b전%궁경상피내류양변%인유두류병독
Loop electrosurgical excision procedure%Interferon alfa-2b suppository%Cervical intraepithelial neoplasia%Human papillomavirus
目的 探讨宫颈环形电切术(LEEP)联合重组人干扰素α-2b栓治疗宫颈上皮内瘤变(CIN)的临床效果.方法 选择经液基细胞学检查(TCT)、宫颈活检病理检查明确诊断为CIN Ⅰ~Ⅲ级患者82例,均于LEEP治疗前应用导流杂交法检测21种亚型人乳头瘤病毒(HPV DNA),均行LEEP治疗,观察组(41例)为LEEP术后加用重组人干扰素α-2b栓治疗3个疗程患者,分别于治疗后6、12个月行TCT及HPV DNA检测以判断两组的疗效.结果 观察组术后6个月治愈率90.2%,术后12个月治愈率100.0%;对照组术后6个月治愈率43.9%,术后12个月治愈率61.0%;两组6、12个月治愈率差异均有统计学意义(x2=19.93、19.89,均P<0.05).结论 宫颈环形电切术联合重组人干扰素α-2b栓治疗CIN疗效优于单纯宫颈环形电切术,提高HPV清除率.
目的 探討宮頸環形電切術(LEEP)聯閤重組人榦擾素α-2b栓治療宮頸上皮內瘤變(CIN)的臨床效果.方法 選擇經液基細胞學檢查(TCT)、宮頸活檢病理檢查明確診斷為CIN Ⅰ~Ⅲ級患者82例,均于LEEP治療前應用導流雜交法檢測21種亞型人乳頭瘤病毒(HPV DNA),均行LEEP治療,觀察組(41例)為LEEP術後加用重組人榦擾素α-2b栓治療3箇療程患者,分彆于治療後6、12箇月行TCT及HPV DNA檢測以判斷兩組的療效.結果 觀察組術後6箇月治愈率90.2%,術後12箇月治愈率100.0%;對照組術後6箇月治愈率43.9%,術後12箇月治愈率61.0%;兩組6、12箇月治愈率差異均有統計學意義(x2=19.93、19.89,均P<0.05).結論 宮頸環形電切術聯閤重組人榦擾素α-2b栓治療CIN療效優于單純宮頸環形電切術,提高HPV清除率.
목적 탐토궁경배형전절술(LEEP)연합중조인간우소α-2b전치료궁경상피내류변(CIN)적림상효과.방법 선택경액기세포학검사(TCT)、궁경활검병리검사명학진단위CIN Ⅰ~Ⅲ급환자82례,균우LEEP치료전응용도류잡교법검측21충아형인유두류병독(HPV DNA),균행LEEP치료,관찰조(41례)위LEEP술후가용중조인간우소α-2b전치료3개료정환자,분별우치료후6、12개월행TCT급HPV DNA검측이판단량조적료효.결과 관찰조술후6개월치유솔90.2%,술후12개월치유솔100.0%;대조조술후6개월치유솔43.9%,술후12개월치유솔61.0%;량조6、12개월치유솔차이균유통계학의의(x2=19.93、19.89,균P<0.05).결론 궁경배형전절술연합중조인간우소α-2b전치료CIN료효우우단순궁경배형전절술,제고HPV청제솔.
Objective To study the effect of combining loop electrosurgical excision procedure (LEEP) and recombinant human interferon α2b (rhIFNα-2b) suppository in treatment of cervical intraepithelial neoplasia (CIN).Methods Prospective,random and control study was conducted in 82 patients with CINⅠ-CINⅢ.Before canting out LEEP to these patients,all women were performed HPV DNA detection by the method of Hybri Max.Among these patients,41 patients were assigned to the studying group,in which the patients were given rhIFNα-2b suppository for three courses of treatment after LEEP.The other 41 patients who carried out LEEP simply were assigned to the control group.Liquid-based ThinPrep cytology test (TCT) and HPV DNA were examined in the sixth and twelfth month after treatment.Results In the studying group,the cure rate was 90.2% when LEEP ended six months,and the cure rate was 100.0% when LEEP ended twelve months.In the control group,the cure rate was 43.9% when LEEP ended six months,and the cure rate was 61.0% when LEEP ended twelve months.In the sixth and twelfth month after LEEP,the difference was significant when we compared the cure rate between the two groups (x2 =19.93,19.89,all P < 0.05).Conclusion The clinical effect of combining LEEP and rhIFNα-2b suppository is better than LEEP in treatment of CIN.The method can remove or destroy the cervical lesions effectively and inhibit HPV replication and spread of HPV infection.